Tyler Zeronda - Dec 31, 2022 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
Chief Financial Officer
Signature
/s/ Mutya Harsch, attorney-in-fact for Tyler Zeronda
Stock symbol
VYNE
Transactions as of
Dec 31, 2022
Transactions value $
-$53
Form type
4
Date filed
1/4/2023, 04:05 PM
Previous filing
Oct 4, 2022
Next filing
Apr 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$53 -354 -0.2% $0.15 173K Dec 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.